| Utestående aktier | 139,700,796 shares |
| Insideraktier | 33 155 366 shares |
| Insynsägande | 23,73 % |
| Totalt antal insynspersoner | 35 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
2.704 %( )
41 out of 11227Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Cogent Biosciences, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Jorn Aldag | 40 090 | ||
|
Atlas Venture Associates IX, L.P.
10% Owner -
|
3 361 535 | 3 361 535 | |
|
Atlas Venture Associates IX, LLC
10% Owner -
|
3 361 535 | 3 361 535 | |
|
Atlas Venture Fund IX, L.P.
10% Owner -
|
3 361 535 | 3 361 535 | |
| Bruce Booth Director - [D] | 3 361 535 | 3 361 535 | |
| Cain Christopher W. | 28 661 | ||
|
Dario Campana
10% Owner -
|
3 095 114 | 773 778 | |
| Seth Ettenberg Chief Scientific Officer - [O] | 0 | 0 | |
| Ltd FIL - | 1 138 274 | 1 138 274 | |
| FMR LLC / Fidelity Management & Research - | 23 240 | 23 240 | |
| Fairmount Funds Management LLC Director - [D] | 9 003 418 | 9 003 418 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Karen Jean Ferrante | 2 753 | ||
| Green John L. Chief Financial Officer - [O] | 3 841 | 3 841 | |
| Geoffrey Hodge | 112 400 | ||
| Peter Evan Harwin | 28 661 | ||
| Evan Kearns | 202 250 | ||
|
Bong Y Koh
10% Owner -
|
4 355 273 | 4 355 273 | |
| Arlene Morris | 14 331 | ||
| Matthew Scott Osborne | 160 400 | ||
| Robert J Perez | 7 131 | ||
| Cole Pinnow Chief Commercial Officer - [O] | 45 848 | 45 848 | |
| Liam Ratcliffe Director - [D] | 897 773 | 897 773 | |
| Andrew R Robbins | 690 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| John Edward Robinson | 250 000 | ||
| Matthew Ros | 2 650 | ||
| Jessica Sachs Chief Medical Officer - [O] | 622 | 622 | |
|
Nimish P Shah
10% Owner -
|
3 904 273 | 4 355 273 | |
| Michael Vasconcelles | 61 900 | ||
|
VHCP Co-Investment Holdings II, LLC
10% Owner -
|
4 355 273 | 4 355 273 | |
|
VHCP Co-Investment Holdings III, LLC
10% Owner -
|
4 355 273 | 4 355 273 | |
|
VHCP Management II, LLC
10% Owner -
|
4 355 273 | 4 355 273 | |
|
VHCP Management III, LLC
10% Owner -
|
4 355 273 | 4 355 273 | |
|
Venrock Healthcare Capital Partners II, L.P.
10% Owner -
|
4 355 273 | 4 355 273 | |
|
Venrock Healthcare Capital Partners III, L.P.
10% Owner -
|
4 355 273 | 4 355 273 | |
| Charles Wilson Chief Executive Officer, Director - [D] [O] | 10 190 228 | 10 190 228 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i COGT / Cogent Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i COGT / Cogent Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-14 | 2025-07-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 9,0000 | 2 777 777 | 25 000 | 9 003 418 | ||||
| 2025-01-15 | 2025-01-14 | 4 | Pinnow Cole | COGT | Common Stock | D | 7,5980 | 43 750 | 332 | 45 848 | ||||
| 2024-06-12 | 2024-06-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 1 500 000 | 6 225 641 | ||||||
| 2024-05-29 | 3 | Pinnow Cole | COGT | Common Stock | D | 700 | ||||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 286 851 | 4 725 641 | ||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | COGT | Common Stock | I | −286 851 | 0 | ||||||
| 2024-02-16 | 2024-02-16 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 7,5000 | 1 166 666 | 8 750 | 4 438 790 | ||||
| 2023-06-13 | 2023-06-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 12,0000 | 800 000 | 9 600 | 3 272 124 | ||||
| 2022-07-01 | 2022-06-30 | 4 | Sachs Jessica | COGT | Common Stock | D | 7,3950 | 622 | 5 | 622 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 8,2500 | 1 200 000 | 9 900 | 2 472 124 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 7,92 | 4,8600 | 2 650 | 13 | 2 650 | |||
| 2022-04-05 | 2022-04-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 7,92 | 4,8600 | 2 753 | 13 | 2 753 | |||
| 2022-01-27 | 2022-01-25 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 225 000 | 1 112 | 225 000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 250 000 | 1 236 | 250 000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Kearns Evan | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 202 250 | 1 000 | 202 250 | |||
| 2022-01-27 | 2022-01-25 | 4 | Robinson John Edward | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 250 000 | 1 236 | 250 000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 690 000 | 3 411 | 690 000 | |||
| 2022-01-04 | 2022-01-03 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,70 | 5,1530 | 2 329 | 12 | 2 329 | |||
| 2022-01-04 | 2021-12-31 | 4 | Sachs Jessica | COGT | Common Stock | D | 6,8170 | 674 | 5 | 674 | ||||
| 2022-01-04 | 2022-01-03 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,70 | 5,1530 | 2 256 | 12 | 2 256 | |||
| 2021-10-05 | 2021-10-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,54 | 5,0317 | 2 385 | 12 | 2 385 | |||
| 2021-10-05 | 2021-10-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,54 | 5,0317 | 2 463 | 12 | 2 463 | |||
| 2021-07-06 | 2021-07-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,02 | 4,7754 | 2 225 | 11 | 2 225 | |||
| 2021-07-06 | 2021-07-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,02 | 4,7754 | 2 513 | 12 | 2 513 | |||
| 2021-05-05 | 2021-05-03 | 4 | Kearns Evan | COGT | Stock Option (Right to Buy) | D | 8,93 | 260 000 | 260 000 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Green John L. | COGT | Common Stock | D | 8,8600 | −17 813 | −158 | 3 841 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 9,08 | 5,6577 | 2 121 | 12 | 2 121 | |||
| 2021-04-05 | 2021-04-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 9,08 | 5,6557 | 2 068 | 12 | 2 068 | |||
| 2021-03-15 | 2021-03-11 | 4 | Harwin Peter Evan | COGT | Stock Option (Right to Buy) | D | 8,45 | 60 000 | 60 000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,45 | 60 000 | 60 000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | CAIN CHRISTOPHER W. | COGT | Stock Option (Right to Buy) | D | 8,45 | 60 000 | 60 000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,45 | 60 000 | 60 000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Shegog Todd | COGT | Stock Option (Right to Buy) | D | 8,45 | 22 500 | 22 500 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Morris Arlene | COGT | Stock Option (Right to Buy) | D | 8,45 | 60 000 | 60 000 | |||||
| 2021-03-01 | 2021-02-25 | 4 | Green John L. | COGT | Common Stock | D | 524 | 21 654 | ||||||
| 2021-02-24 | 2021-02-22 | 4 | Shegog Todd | COGT | Stock Option (Right to Buy) | D | 8,59 | 37 500 | 37 500 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 10,17 | 315 200 | 315 200 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 10,17 | 270 746 | 270 746 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 10,17 | 111 300 | 111 300 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 10,17 | 126 500 | 126 500 | |||||
| 2021-02-02 | 2021-02-01 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 9,10 | 400 000 | 400 000 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 7,62 | 1 641 | 1 641 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 7,62 | 1 575 | 1 575 | |||||
| 2020-12-09 | 2020-12-07 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 12,76 | 456 693 | 456 693 | |||||
| 2020-12-07 | 2020-12-01 | 4 | Green John L. | COGT | Common Stock | D | 1 748 | 1 748 | ||||||
| 2020-10-27 | 2020-10-23 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 2,79 | 7 442 421 | 7 442 421 | |||||
| 2020-10-15 | 2020-10-13 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 2,89 | 695 700 | 695 700 | |||||
| 2020-10-08 | 2020-05-12 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4638 | −98 200 | −46 | 3 095 114 | ||||
| 2020-10-08 | 2020-05-11 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4524 | −77 719 | −35 | 3 193 314 | ||||
| 2020-10-08 | 2020-05-11 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4639 | −22 281 | −10 | 3 271 033 | ||||
| 2020-10-08 | 2020-05-08 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4639 | −100 000 | −46 | 3 293 314 | ||||
| 2020-10-08 | 2020-05-07 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4143 | −100 000 | −41 | 3 393 314 | ||||
| 2020-10-08 | 2020-05-06 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4009 | −1 800 | −1 | 3 493 314 | ||||
| 2020-10-08 | 2020-05-05 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4018 | −135 484 | −54 | 3 495 114 | ||||
| 2020-10-08 | 2020-05-04 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4006 | −4 795 | −2 | 3 630 598 | ||||
| 2020-10-08 | 2020-05-01 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4100 | −800 | −0 | 3 635 393 | ||||
| 2020-10-08 | 2020-04-30 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4021 | −75 994 | −31 | 3 636 193 | ||||
| 2020-10-08 | 2020-04-29 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4061 | −382 927 | −156 | 3 712 187 | ||||
| 2020-10-08 | 2020-04-28 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4099 | −15 048 | −6 | 4 095 114 | ||||
| 2020-10-08 | 2020-04-27 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4032 | −242 579 | −98 | 4 110 162 | ||||
| 2020-10-08 | 2020-04-20 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4006 | −12 606 | −5 | 4 352 741 | ||||
| 2020-10-08 | 2020-04-17 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3902 | −65 540 | −26 | 4 365 347 | ||||
| 2020-10-08 | 2020-04-16 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3826 | −600 | −0 | 4 430 887 | ||||
| 2020-10-08 | 2020-04-15 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3841 | −82 782 | −32 | 4 431 487 | ||||
| 2020-10-08 | 2020-04-14 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4000 | −44 006 | −18 | 4 514 269 | ||||
| 2020-10-08 | 2020-04-14 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4024 | −54 967 | −22 | 4 558 275 | ||||
| 2020-10-08 | 2020-04-09 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3287 | −420 292 | −138 | 4 613 242 | ||||
| 2020-10-08 | 2020-04-08 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3510 | −100 | −0 | 5 033 534 | ||||
| 2020-10-08 | 2020-04-07 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3500 | −11 400 | −4 | 5 033 634 | ||||
| 2020-10-08 | 2020-04-06 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3500 | −50 080 | −18 | 5 045 034 | ||||
| 2020-10-02 | 2020-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,26 | 1,3518 | 8 878 | 12 | 8 878 | |||
| 2020-10-02 | 2020-10-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 2,26 | 1,3518 | 9 247 | 13 | 9 247 | |||
| 2020-08-31 | 2020-08-27 | 4 | Harwin Peter Evan | UMRX | Director Stock Option (Right to Buy) | D | 2,77 | 28 661 | 28 661 | |||||
| 2020-08-31 | 2020-08-27 | 4 | CAIN CHRISTOPHER W. | UMRX | Director Stock Option (Right to Buy) | D | 2,77 | 28 661 | 28 661 | |||||
| 2020-08-18 | 2020-08-18 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,6200 | 101 000 | 265 | 4 355 273 | ||||
| 2020-08-18 | 2020-08-17 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,5700 | 250 000 | 642 | 4 254 273 | ||||
| 2020-08-18 | 2020-08-14 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,3000 | 100 000 | 230 | 4 004 273 | ||||
| 2020-08-18 | 3 | Shah Nimish P By funds | UMRX | Common Stock | I | 3 904 273 | ||||||||
| 2020-07-13 | 2020-07-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Series A Convertible Preferred Stock | I | 880,0000 | 19 035 | 16 751 | 55 500 | ||||
| 2020-07-13 | 2020-07-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Series A Convertible Preferred Stock | I | 880,0000 | 3 692 | 3 249 | 11 914 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Restricted Stock Units | D | −109 459 | 0 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Common Stock | D | 2,2000 | −31 873 | −70 | 77 586 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Common Stock | D | 109 459 | 109 459 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Series A Convertible Preferred Stock | I | 36 465 | 36 465 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Series A Convertible Preferred Stock | I | 8 222 | 8 222 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Common Stock | I | 5 088 497 | 5 088 497 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Common Stock | I | 1 147 406 | 1 147 406 | ||||||
| 2020-07-06 | 2020-07-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 61 338 | 19 | 61 338 | |||
| 2020-07-06 | 2020-07-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 38 487 | 12 | 38 487 | |||
| 2020-07-06 | 2020-07-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 35 280 | 11 | 35 280 | |||
| 2020-07-06 | 2020-07-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 40 090 | 13 | 40 090 | |||
| 2020-06-11 | 2020-06-09 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14 331 | 14 331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Morris Arlene | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14 331 | 14 331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14 331 | 14 331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14 331 | 14 331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14 331 | 14 331 | |||||
| 2020-04-08 | 2020-04-06 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 86 735 | 19 | 86 735 | |||
| 2020-04-08 | 2020-04-06 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 54 422 | 12 | 54 422 | |||
| 2020-04-08 | 2020-04-06 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 49 887 | 11 | 49 887 | |||
| 2020-04-08 | 2020-04-06 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 56 690 | 13 | 56 690 | |||
| 2020-02-13 | 2020-02-11 | 4 | Ettenberg Seth | UMRX | Stock Option | D | 0,80 | 153 600 | 153 600 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Green John L. | UMRX | Stock Option | D | 0,80 | 64 400 | 64 400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | HODGE GEOFFREY | UMRX | Stock Option | D | 0,80 | 112 400 | 112 400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Osborne Matthew Scott | UMRX | Stock Option | D | 0,80 | 160 400 | 160 400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Sachs Jessica | UMRX | Stock Option | D | 0,80 | 133 200 | 133 200 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 39 996 | 18 | 39 996 | |||
| 2020-01-06 | 2020-01-02 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 24 274 | 11 | 24 274 | |||
| 2020-01-06 | 2020-01-02 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 29 790 | 14 | 29 790 | |||
| 2020-01-06 | 2020-01-02 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 26 480 | 12 | 26 480 | |||
| 2019-11-21 | 2019-11-19 | 4 | Green John L. | UMRX | Restricted Stock Units | D | 109 459 | 109 459 | ||||||
| 2019-11-21 | 2019-11-19 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,69 | 280 000 | 280 000 | |||||
| 2019-10-03 | 2019-10-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 20 611 | 18 | 20 611 | |||
| 2019-10-03 | 2019-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 13 646 | 12 | 13 646 | |||
| 2019-10-03 | 2019-10-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 12 509 | 11 | 12 509 | |||
| 2019-10-03 | 2019-10-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 15 352 | 14 | 15 352 | |||
| 2019-07-29 | 2019-07-26 | 4 | Morris Arlene | UMRX | Stock Option (Right to Buy) | D | 2,05 | 28 661 | 28 661 | |||||
| 2019-07-29 | 2019-07-26 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 2,05 | 28 661 | 28 661 | |||||
| 2019-07-22 | 2019-07-19 | 4 | Sachs Jessica | UMRX | Stock Option (Right to Buy) | D | 2,61 | 123 800 | 123 800 | |||||
| 2019-07-03 | 2019-07-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 7 608 | 14 | 7 608 | |||
| 2019-07-03 | 2019-07-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 10 285 | 18 | 10 285 | |||
| 2019-07-03 | 2019-07-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 6 199 | 11 | 6 199 | |||
| 2019-06-25 | 2019-06-24 | 4 | Osborne Matthew Scott | UMRX | Stock Option (Right to Buy) | D | 2,44 | 190 000 | 190 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14 331 | 14 331 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14 331 | 14 331 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14 331 | 14 331 | |||||
| 2019-06-18 | 2019-06-14 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 2,43 | 1,6654 | 7 881 | 13 | 7 881 | |||
| 2019-06-18 | 2019-06-14 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 2,43 | 1,6654 | 7 131 | 12 | 7 131 | |||
| 2019-04-26 | 2019-04-24 | 4 | Green John L. | UMRX | Stock Option (Right to Buy) | D | 3,52 | 16 814 | 16 814 | |||||
| 2019-04-23 | 2019-04-19 | 4/A | Green John L. | UMRX | Stock Option (Right to Buy) | D | 3,60 | 21 017 | 21 017 | |||||
| 2019-04-11 | 2019-03-01 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 4,36 | 69 700 | 69 700 | |||||
| 2019-04-11 | 2019-03-01 | 4 | Green John L. | UMRX | Stock Option (Right to Buy) | D | 4,36 | 21 017 | 21 017 | |||||
| 2019-04-11 | 2019-03-01 | 4 | HODGE GEOFFREY | UMRX | Stock Option (Right to Buy) | D | 4,36 | 28 000 | 28 000 | |||||
| 2019-04-11 | 2019-03-01 | 4 | VASCONCELLES MICHAEL | UMRX | Stock Option (Right to Buy) | D | 4,36 | 61 900 | 61 900 | |||||
| 2019-04-11 | 2019-03-01 | 4 | WILSON CHARLES | UMRX | Stock Option (Right to Buy) | D | 4,36 | 174 400 | 174 400 | |||||
| 2019-04-03 | 2019-03-25 | 4/A | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 329 145 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4 047 | 11 | 4 047 | |||
| 2019-04-03 | 2019-04-01 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4 369 | 12 | 4 369 | |||
| 2019-04-03 | 2019-04-01 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4 829 | 13 | 4 829 | |||
| 2019-04-03 | 2019-04-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4 966 | 14 | 4 966 | |||
| 2019-04-03 | 2019-04-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 6 714 | 18 | 6 714 | |||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | 11 485 | 329 145 | |||||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,1214 | −11 485 | −47 | 0 | ||||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 340 630 | |||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,2536 | −11 485 | −49 | 0 | ||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2019-01-04 | 2019-01-02 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4 999 | 13 | 4 999 | |||
| 2019-01-04 | 2019-01-02 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 6 757 | 18 | 6 757 | |||
| 2019-01-04 | 2019-01-02 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4 073 | 11 | 4 073 | |||
| 2019-01-04 | 2019-01-02 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4 397 | 12 | 4 397 | |||
| 2019-01-04 | 2019-01-02 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4 860 | 13 | 4 860 | |||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 352 115 | |||||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,0476 | −11 485 | −46 | 0 | ||||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 363 600 | |||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 7,0043 | −11 485 | −80 | 0 | ||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 375 085 | |||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 8,4633 | −11 485 | −97 | 0 | ||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2 171 | 14 | 2 171 | |||
| 2018-10-03 | 2018-10-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2 935 | 18 | 2 935 | |||
| 2018-10-03 | 2018-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 1 769 | 11 | 1 769 | |||
| 2018-10-03 | 2018-10-01 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 1 910 | 12 | 1 910 | |||
| 2018-10-03 | 2018-10-01 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2 111 | 13 | 2 111 | |||
| 2018-09-26 | 2018-07-26 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1 361 | 12 | 1 361 | |||
| 2018-09-26 | 2018-07-26 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1 504 | 13 | 1 504 | |||
| 2018-09-26 | 2018-07-26 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1 547 | 13 | 1 547 | |||
| 2018-09-26 | 2018-07-26 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 2 092 | 18 | 2 092 | |||
| 2018-09-26 | 2018-09-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 12,4668 | −11 485 | −143 | 0 | ||||
| 2018-09-26 | 2018-09-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11 485 | 2 | 11 485 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | −11 485 | 386 570 | |||||
| 2018-09-26 | 2018-07-26 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1 261 | 11 | 1 261 | |||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Series B Preferred Stock | I | −877 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Series B Preferred Stock | I | −73 065 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Series B Preferred Stock | I | −13 505 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Series A Preferred Stock | I | −35 614 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Series A Preferred Stock | I | −2 968 650 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Series A Preferred Stock | I | −548 702 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Common Stock | I | 558 | 23 240 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Common Stock | I | 22 682 | 22 682 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Common Stock | I | 46 534 | 1 937 235 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Common Stock | I | 1 890 701 | 1 890 701 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 12,0000 | 94 052 | 1 129 | 452 115 | ||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 8 601 | 358 063 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 349 462 | 349 462 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Series B Preferred Stock | D | −42 931 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Series A Preferred Stock | D | −1 744 310 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Common Stock | D | 27 342 | 1 138 274 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Common Stock | D | 1 110 932 | 1 110 932 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Series B Preferred Stock | D | −83 037 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Series A Preferred Stock | D | −3 184 446 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 12,0000 | 94 052 | 1 129 | 3 361 535 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 83 037 | 3 267 483 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 3 184 446 | 3 184 446 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Series B Preferred Stock | I | −83 037 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Series A Preferred Stock | I | −3 184 446 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 12,0000 | 94 052 | 1 129 | 3 361 535 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 83 037 | 3 267 483 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 3 184 446 | 3 184 446 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Series B Preferred Stock | I | −977 836 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Series B Preferred Stock | I | −977 835 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 12,0000 | 275 000 | 3 300 | 897 773 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 12,0000 | 275 000 | 3 300 | 897 773 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 622 773 | 622 773 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 622 772 | 622 772 | ||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10 190 228 | ||||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10 190 228 | ||||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10 190 228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10 190 228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10 190 228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10 190 228 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
